We are live on
!
Find out more
NCM
Nantahala Capital Management Portfolio holdings
AUM
$1.6B
1-Year Est. Return
121.58%
This Fund
S&P 500
1 Year Est. Return
+121.58%
AUM
$1.6B
AUM Growth
-$75.4M
(-4.5%)
Holding
158
Top Buys
| 1 | +$29.6M | |
| 2 | +$22.9M | |
| 3 | +$22.7M | |
| 4 |
Verastem
VSTM
|
+$19.3M |
| 5 |
The Bancorp
TBBK
|
+$18.5M |
Top Sells
| 1 | +$32.3M | |
| 2 | +$30.5M | |
| 3 | +$30.2M | |
| 4 |
RAPT
RAPT Therapeutics
RAPT
|
+$25.5M |
| 5 |
Globus Medical
GMED
|
+$19.6M |
Sector Composition
| 1 | Healthcare | 61.03% |
| 2 | Consumer Discretionary | 16.41% |
| 3 | Financials | 6.64% |
| 4 | Communication Services | 4.74% |
| 5 | Industrials | 2.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Herbalife
HLF
$1.17B
| $19.9M | 1.24% |
1,353,653
+471,796
|
|
||
27
IMAX
IMAX
$2.18B
| $19.6M | 1.22% |
515,554
+38,462
|
|
||
|
28
Verastem
VSTM
$322M
| $19M | 1.19% |
3,584,820
+3,122,680
|
|
||
29
BioCryst Pharmaceuticals
BCRX
$2.13B
| $18.9M | 1.18% |
1,987,397
+631,020
|
|
||
30
Avalo Therapeutics
AVTX
$674M
| $18.4M | 1.15% |
1,235,000
|
|
||
31
The RMR Group
RMR
$355M
| $17.8M | 1.11% |
1,147,902
|
|
||
32
Rayonier Advanced Materials
RYAM
$533M
| $17.7M | 1.11% |
1,600,000
-200,000
|
|
||
33
Geron
GERN
$725M
| $16.7M | 1.04% |
11,225,000
+2,200,000
|
|
||
34
Benitec Biopharma
BNTC
$364M
| $15.3M | 0.96% |
1,438,371
+400,000
|
|
||
|
ABVX
35
Abivax
ABVX
$7.94B
| $15.3M | 0.95% |
137,237
-15,998
|
|
||
36
Integer Holdings
ITGR
$3.18B
| $15.1M | 0.94% |
172,000
+70,000
|
|
||
37
Keros Therapeutics
KROS
$199M
| $15M | 0.94% |
1,360,419
+1,000,000
|
|
||
38
Jack in the Box
JACK
$222M
| $14.9M | 0.93% |
1,542,715
+676,725
|
|
||
|
JCAP
39
Jefferson Capital
JCAP
$891M
| $14.4M | 0.9% |
750,000
+150,000
|
|
||
40
Aura Biosciences
AURA
$659M
| $14.2M | 0.88% |
2,117,697
|
|
||
41
Usana Health Sciences
USNA
$347M
| $14.2M | 0.88% |
810,074
+225,000
|
|
||
42
Vaxcyte
PCVX
$6.68B
| $13.9M | 0.87% |
+238,746
|
|
||
43
MiMedx Group
MDXG
$547M
| $13.4M | 0.84% |
3,397,299
+980,910
|
|
||
44
Assertio
ASRT
$152M
| $13.2M | 0.82% |
692,335
+105,000
|
|
||
45
Distribution Solutions Group
DSGR
$1.27B
| $13M | 0.81% |
494,581
+164,581
|
|
||
|
AGMB
46
AgomAb Therapeutics NV
AGMB
$490M
| $12.9M | 0.8% |
+1,200,000
|
|
||
|
HLXC
47
Helix Acquisition Corp III
HLXC
$227M
| $12.7M | 0.79% |
+1,250,000
|
|
||
48
Apyx Medical
APYX
$208M
| $12.7M | 0.79% |
3,440,304
-533,787
|
|
||
|
SLN
49
Silence Therapeutics
SLN
$284M
| $11.3M | 0.71% |
2,146,731
+604,304
|
|
||
50
Janux Therapeutics
JANX
$818M
| $11.3M | 0.7% |
+809,914
|
|